Publication Date
March 1, 2008
Publication Information
Sadiq SA, Rammal M, and Sara G. Mult Scler. 2008; 14(2): 272-273.
We report the first case of chronic myeloid leukemia (CML) in a patient with multiple sclerosis (MS) diagnosed within two years of receiving mitoxantrone therapy. Previously only acute forms of leukemia particularly acute promyelocytic leukemia (APL) have been associated with mitoxantrone treatment in MS. This underscores the need for only using mitoxantrone in severe treatment-unresponsive cases of MS.
Tisch MS Research Center of New York
521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900
Support Tisch MS
Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.